American Shared Hospital Services (AMS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 revenue increased 16% sequentially and 0.2% year-over-year to $7.1M, driven by direct patient services and international expansion, offsetting declines in leasing revenue.
Net loss attributable to shareholders was $280K ($0.04/share) for Q2 2025, compared to net income of $3.6M in Q2 2024, which included a $3.7M bargain purchase gain from the Rhode Island acquisition.
Direct patient services revenue rose due to the Rhode Island acquisition and Puebla, Mexico facility, while equipment leasing revenue declined due to contract expirations and lower Gamma Knife volumes.
Four consecutive years of significant revenue growth, nearly doubling since 2021, and three years of profitability.
Strategic focus on operational efficiency, business development, and long-term shareholder value.
Financial highlights
Q2 2025 revenue was $7.1M, up 16% sequentially and slightly up year-over-year; six months revenue was $13.2M, up $911K year-over-year.
Direct patient services revenue was $3.5M in Q2 2025, up 11-12% year-over-year; equipment leasing revenue was $3.57M, down 8% year-over-year.
Q2 2025 gross margin was $1.6M–$1.63M, up 73% sequentially but down 34% year-over-year.
Q2 2025 net loss was $280K ($0.04/share), improved from Q1 2025 loss of $625K, but down from Q2 2024 net income of $3.6M.
Adjusted EBITDA for Q2 2025 was $1.7M, up from $949K in Q1 2025, but down from $2M in Q2 2024.
Outlook and guidance
Management expects continued growth in direct patient services from Rhode Island and Puebla, Mexico, with new centers in Mexico and Rhode Island expected to start up in late 2025.
Anticipation of revenue from the new Gamma Knife center in Guadalajara, Mexico, by year-end.
The company believes cash on hand, operations, and credit line are sufficient for debt and working capital needs over the next 12 months.
Ongoing investments in new equipment and facility upgrades are planned, with $8.4M in equipment commitments and $11.9M in service commitments.
Strategic initiatives focus on operational efficiency, economies of scale, and business development pipeline to drive future profitability.
Latest events from American Shared Hospital Services
- Q2 2024 net income surged to $3.6M on 27% revenue growth and a major acquisition gain.AMS
Q2 20241 Feb 2026 - Q3 revenue rose 36.3% to $6.99M, but margins fell on higher costs and lower Gamma Knife volumes.AMS
Q3 202414 Jan 2026 - Strong FY 2024 growth led by direct patient services and international expansion.AMS
Q4 202425 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, and governance, with focus on diversity.AMS
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification June 26, 2025.AMS
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 17% to $6.1M, led by direct patient services and new centers, but net loss widened.AMS
Q1 202525 Nov 2025 - Q3 2025 revenue and EBITDA rose, net loss narrowed, and expansion investments accelerated.AMS
Q3 202517 Nov 2025